Skip to content
  • Wednesday, 10 June 2026
  • 9:41 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Gilead Sciences to Acquire Ouro Medicines for $2.2 Billion, Ushering in New Era of T-Cell Engagers in Autoimmune Diseases
Pharmaceutical R&D

Gilead Sciences to Acquire Ouro Medicines for $2.2 Billion, Ushering in New Era of T-Cell Engagers in Autoimmune Diseases

Teuku Ryan Mar 24, 2026 0

Gilead Sciences is poised to make a significant entry into the burgeoning field of T-cell engagers (TCEs) with its $2.2…

Read More
Pharmaceutical R&D

Novartis Acquires Promising Breast Cancer Drug SNV4818 from Synnovation Therapeutics for Up to $3 Billion

Teuku Ryan Mar 20, 2026 0

Novartis has announced a significant strategic move to bolster its oncology pipeline with the acquisition of SNV4818, an investigational oral…

Read More

Posts pagination

1 … 6 7
Precision DNA editing targets root cause of severe childhood epilepsy in a preclinical study.Practical NLP in the Browser with Transformers.jsOptovolution: Harnessing Light and Evolution for Dynamic Proteins and Cellular ComputationA Novel Mechanical Ratchet Mechanism Drives Cell Division in Large Embryonic Cells, Challenging Textbook Models
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
Optimizing spaCy for Production-Grade NLP: Advanced Techniques for Speed and AccuracyForests’ Ancient Carbon Cycle Disrupted by Pervasive Nitrogen Pollution, New Study RevealsTWiV 1292: Clinical update with Dr. Daniel GriffinCornell University Researchers Develop Breakthrough Nonhormonal Male Contraceptive Targeting Cellular Meiosis
YOU MAY HAVE MISSED
Data Science & Bioinformatics
Optimizing spaCy for Production-Grade NLP: Advanced Techniques for Speed and Accuracy
Evan Lee Salim Jun 6, 2026
Molecular & Cell Biology
Forests’ Ancient Carbon Cycle Disrupted by Pervasive Nitrogen Pollution, New Study Reveals
Angie Faith Jun 6, 2026
Microbiology & Immunology
TWiV 1292: Clinical update with Dr. Daniel Griffin
Lina Irawan Jun 6, 2026
Stem Cell & Regenerative Medicine
Cornell University Researchers Develop Breakthrough Nonhormonal Male Contraceptive Targeting Cellular Meiosis
Dwi Wanna Jun 6, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ